THC Therapeutics (THC Therapeutics) Change In Receivables : $0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics Change In Receivables?

THC Therapeutics's change in receivables for the quarter that ended in Jul. 2023 was $0.00 Mil. It means THC Therapeutics's Accounts Receivable stayed the same from Apr. 2023 to Jul. 2023 .

THC Therapeutics's change in receivables for the fiscal year that ended in Jul. 2023 was $0.00 Mil. It means THC Therapeutics's Accounts Receivable stayed the same from Jul. 2022 to Jul. 2023 .

THC Therapeutics's Accounts Receivable for the quarter that ended in Jul. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. THC Therapeutics's liquidation value for the three months ended in Jul. 2023 was $-3.32 Mil.

THC Therapeutics Change In Receivables Historical Data

The historical data trend for THC Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Change In Receivables Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Change In Receivables

Get a 7-Day Free Trial

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

THC Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

THC Therapeutics (OTCPK:THCT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

THC Therapeutics's Days Sales Outstanding for the quarter that ended in Jul. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, THC Therapeutics's accounts receivable are only considered to be worth 75% of book value:

THC Therapeutics's liquidation value for the quarter that ended in Jul. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	3.323	+	0.75 * 0	+	0.5 * 0
=	-3.32

THC Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX